Femtechinsiderfeed

Imagion Biosystems (ASX: IBX) has secured firm commitments for AU$3.75 million (US$2.59 million) in new capital following FDA clearance of its IND application for a Phase 2 clinical trial of MagSense, a molecular MRI imaging agent, in HER2+ breast cancer. The company has begun trial activation activities and expects to start patient recruitment later this year. MagSense uses ...

Muun Health, the Estonia-based company developing a wearable device for continuous female hormone monitoring, has secured a €700K grant from Enterprise Estonia to develop its Smart Patch Platform. The grant is part of a €1 million project focused on advancing the sensor’s bioselective layer to enable real-time hormone measurement from interstitial fluid. Muun Health is develo...

Avni Wellness, a Mumbai-based women’s health startup, has secured Rs 4 crore (approximately $470,000) in seed funding led by Proteus Partners, with participation from angel investors including Puru Gupta, Sreejith Moolayil, A. Velumani, and Somya Nigam. The capital will strengthen digital commerce capabilities, expand the company’s cycle nutrition product range, grow its wome...

The 42nd Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE) is currently taking place in London, bringing together researchers and clinicians presenting the latest science in fertility, IVF, and reproductive health. The studies presented at ESHRE each year shape how fertility care is understood and delivered, and often preview the research tha...

Oova, a hormone intelligence platform, has launched an integration with Oura that allows users to sync sleep and recovery data from the Oura Ring directly alongside daily hormone patterns and symptom tracking in the Oova app. The integration brings hormone data, sleep metrics (including readiness and recovery scores), and symptom tracking onto a single timeline – helping wome...